Alexander Nystrom

Hugstetter Str. 55
Freiburg, BW 79106, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 96 publications

Targeting, Mutagenesis, and Functional Testing Strategies for Large Collagens.

Targeting, Mutagenesis, and Functional Testing Strategies for Large Collagens.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: September 02, 2026

The extracellular matrix as a central regulator of aging and tissue adaptation to exercise.

The extracellular matrix as a central regulator of aging and tissue adaptation to exercise.

Journal: American journal of physiology. Cell physiology

Published: June 04, 2026

Wound-Healing Effects of Birch Bark and Propolis Extracts on Epidermolysis Bullosa Keratinocytes.

Wound-Healing Effects of Birch Bark and Propolis Extracts on Epidermolysis Bullosa Keratinocytes.

Journal: International journal of molecular sciences

Published: May 29, 2026

N-acetylcysteine exerts senescence-selective antifibrotic effects in fibroblast from chronic wounds in recessive dystrophic epidermolysis bullosa.

N-acetylcysteine exerts senescence-selective antifibrotic effects in fibroblast from chronic wounds in recessive dystrophic epidermolysis bullosa.

Journal: The British journal of dermatology

Published: December 11, 2025

Systemic clinical-grade recombinant decorin reduces disease burden and fibrosis in advanced recessive dystrophic epidermolysis bullosa.

Systemic clinical-grade recombinant decorin reduces disease burden and fibrosis in advanced recessive dystrophic epidermolysis bullosa.

Journal: Molecular therapy. Advances

Published: November 25, 2025

Impaired skin reinnervation in epidermolysis bullosa due to neurotrophic deficiency.

Impaired skin reinnervation in epidermolysis bullosa due to neurotrophic deficiency.

Journal: Pain

Published: October 23, 2025

Transforming Growth Factor-β-Mediated Fibrotic Remodeling Drives Chronic Kidney Disease in Methylmalonic Aciduria and Propionic Aciduria-Identification of a New Therapeutic Target.

Transforming Growth Factor-β-Mediated Fibrotic Remodeling Drives Chronic Kidney Disease in Methylmalonic Aciduria and Propionic Aciduria-Identification of a New Therapeutic Target.

Journal: Journal of inherited metabolic disease

Published: August 06, 2025

Safe and Efficacious Permanent Removal of Large COL7A1 Exons for Gene Reframing as a Reliable Therapeutic Strategy for Recessive Dystrophic Epidermolysis Bullosa.

Safe and Efficacious Permanent Removal of Large COL7A1 Exons for Gene Reframing as a Reliable Therapeutic Strategy for Recessive Dystrophic Epidermolysis Bullosa.

Journal: Human gene therapy

Published: May 28, 2025

Are you listening: cellular signaling in ECM-driven diseases.

Are you listening: cellular signaling in ECM-driven diseases.

Journal: American journal of physiology. Cell physiology

Published: April 29, 2025

Extracellular matrix alterations in inflammatory skin diseases: emerging biomarkers and clinical implications.

Extracellular matrix alterations in inflammatory skin diseases: emerging biomarkers and clinical implications.

Journal: Clinical and experimental dermatology

Published: April 15, 2025

Inflammatory modulation by cord blood stem cells prevented digit deformation in recessive dystrophic epidermolysis bullosa.

Inflammatory modulation by cord blood stem cells prevented digit deformation in recessive dystrophic epidermolysis bullosa.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: February 20, 2025

Progress in skin gene therapy: From the inside and out.

Progress in skin gene therapy: From the inside and out.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 31, 2025

Showing 1-12 of 96

Last Updated: 09/26/2026